Industry News
La Trobe research developing allergy-free ryegrass
Melbourne-based researchers are developing a transgenic rye grass that will reduce the risk of hay fever in allergy sufferers. [ + ]
Import undertakings from Monsanto and Nufarm
Monsanto and Nufarm have given Australia's consumer watchdog court-enforceable undertakings that they will not try to stop agricultural glyphosate herbicides being imported from China. [ + ]
Tech CEOs tip biotech growth
CEOs of Australia's leading technology companies believe that the biotechnology and internet security sectors have the greatest potential for growth in the next 12 months, according to a Deloitte industry survey. [ + ]
Peptech to profit in UK
Peptech will reap further profits from its Remicade anti-TNF antibody in Britain. [ + ]
Hawke steps down from Autogen board
Former Prime Minister Bob Hawke has resigned as a director of Autogen's board, citing heavy business and personal commitments. [ + ]
Government must help biotech: Clarke
The suspension of the Federal government's R&D Start program, purportedly for being too successful, flew in the face of Australia's need to compete in the global biotechnology arena, Prof Adrienne Clarke has warned. [ + ]
Study to look at ecosystems' genetic viability
A study is underway in NSW and WA to examine endangered ecosystems using genetic techniques. [ + ]
Award nominations open
The Ian Clunies Ross Memorial Foundation has called for nominations for its 2003 National Science and Technology Award. [ + ]
BioDiem appointment ramps up market bid
Drug development company BioDiem has appointed a pharmaceutical industry heavyweight to its board in the lead-up to a public listing this year. [ + ]
Bad data warning over public gene databases
Some of the most-used global databases of DNA and amino acid sequences are riddled with errors and there is no quick fix in sight. [ + ]
Work begins on Chemeq plant
Perth-based research pharma Chemeq (ASX: CMQ) has begun work on its $25 million production facility at Rockingham, in the city's south. [ + ]
Aust officials 'negative' on global GM protocol
Australia has no plans to sign an international protocol covering the environmental impact of trade in living genetically modified organisms (LMOs), with trade officials calling for more discussion on how it would affect grain trade. [ + ]
Analysts explain ResMed share tumble
Investors have lost patience with companies failing to deliver on expectations, analysts said today (Monday, May 6), with ResMed the latest stock hit by their wrath. [ + ]
Preparing to ride the resurgence of science
The ANU's new Dean of the Faculty of Science believes the outlook for Australian science is positive - with a resurgence of support on the horizon.
[ + ]A decade of achievement for ANSTO's cyclotron
Australia's National Medical Cyclotron (NMC) - the electrical machine that has given doctors the power to accurately diagnose thousands of Australians - is celebrating ten years of operation.
[ + ]
